Wolverine Asset Management’s Strata Critical Medical Inc Warrants SRTAW Stock Holding History

Wolverine Asset Management’s Portfolio SRTAW Stock Details SRTAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-146,268	Closed	-$731	–	1692
2026 Q1	$731	Buy	146,268 +20,832	+17%	+$1.57K	﹤0.01%	1610
2025 Q4	$13.5K	Buy	125,436 +10,114	+9%	+$1.68K	﹤0.01%	1396
2025 Q3	$24K	Buy	115,322 +33,266	+41%	+$6.53K	﹤0.01%	1279
2025 Q2	$17.3K	Buy	82,056 +71,700	+692%	+$13.8K	﹤0.01%	1330
2025 Q1	$2.23K	Sell	10,356 -15,558	-60%	-$5.16K	﹤0.01%	1423
2024 Q4	$10.6K	Sell	25,914 -24,881	-49%	-$8.29K	﹤0.01%	1352
2024 Q3	$9.65K	Sell	50,795 -9,037	-15%	-$1.64K	﹤0.01%	1333
2024 Q2	$10.1K	Buy	59,832 +36,412	+155%	+$9.35K	﹤0.01%	1327
2024 Q1	$2.45K	Buy	+23,420	New	+$3.98K	﹤0.01%	1455

Wolverine Asset Management's SRTAW Position: Q2 2026 in Review

Wolverine Asset Management sold out of Strata Critical Medical Inc Warrants (SRTAW) in Q2 2026, closing a stake of 146,268 shares — an estimated $731 sold.

Wolverine Asset Management first reported a position in SRTAW in Q1 2024 and held it in 9 quarters. The position peaked at $24K in Q3 2025. 0 funds tracked by Wall St. Rank hold SRTAW as of Q2 2026.

Wolverine Asset Management reported no remaining Strata Critical Medical Inc Warrants position as of Q2 2026 after selling out during the quarter.
Wolverine Asset Management sold 146,268 Strata Critical Medical Inc Warrants shares in Q2 2026, an estimated $731.
Wolverine Asset Management first reported a position in Strata Critical Medical Inc Warrants in Q1 2024 and held it in 9 quarters.
Wolverine Asset Management's Strata Critical Medical Inc Warrants position peaked at $24K in Q3 2025.
0 funds tracked by Wall St. Rank held Strata Critical Medical Inc Warrants as of Q2 2026.

Based on Wolverine Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.